Charles City, IA, United States of America

Paul Alan Jass


Average Co-Inventor Count = 2.9

ph-index = 4

Forward Citations = 41(Granted Patents)


Location History:

  • Charles City, IA (US) (2000 - 2012)
  • Peculiar, MO (US) (2013)

Company Filing History:


Years Active: 2000-2013

Loading Chart...
13 patents (USPTO):

Title: Paul Alan Jass: Innovator in Pharmaceutical Chemistry

Introduction

Paul Alan Jass is a notable inventor based in Charles City, Iowa, with a significant contribution to the field of pharmaceutical chemistry. He holds a total of 13 patents, showcasing his innovative approaches to drug development and synthesis.

Latest Patents

Among his latest patents, Jass has developed methods and compositions for the preparation of amphetamine conjugates and salts thereof. This invention provides methods for preparing amphetamine conjugates, such as lisdexamfetamine and homoarginine-D-amphetamine, utilizing a chloramphetamine intermediate. Another significant patent involves a method of making piperidine derivatives, including sufentanil, where a quaternary ammonium salt of an appropriate piperidine is reacted with a corresponding 4-NOsulfonate ester to produce high-purity piperidine derivatives.

Career Highlights

Throughout his career, Jass has worked with prominent companies in the pharmaceutical industry, including Cambrex Charles City, Inc. and Bristol-Myers Squibb Company. His work has significantly impacted the development of various pharmaceutical products.

Collaborations

Jass has collaborated with notable colleagues, including Keith Ramig and John J. Venit, contributing to advancements in their respective fields.

Conclusion

Paul Alan Jass is a distinguished inventor whose work in pharmaceutical chemistry has led to innovative solutions in drug synthesis. His contributions continue to influence the industry and enhance therapeutic options available to patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…